Only 1 rural county still at risk of having no ACA insurer

Less than a month ago, CMS reported 40 counties were in danger of having no insurer offering coverage through the Affordable Care Act (ACA) exchange. As of Aug. 21, that number had shrunk to just one: Paulding County, Ohio.

According to the Kaiser Family Foundation, an unnamed insurer has stepped in to cover the other potentially bare county, Menominee County, Wisconsin, which had only 47 exchange enrollees in 2017. Paulding County, Ohio, had 334 and is one of many counties affected by Anthem scaling back its ACA participation.

The number of potentially bare counties has steadily dwindled, with pockets of Indiana, Missouri, Nevada, Ohio, Tennessee and Washington once at risk of having no ACA insurer, a possibility the law didn’t consider. Centene stepped in to cover many of the at-risk areas, including a recent expansion in rural Nevada.

Competition has decreased, however. CMS said 1,486 counties—more than 45 percent of all U.S. counties—will have only one insurer on the exchange in 2018. Eight states—Alabama, Alaska, Iowa, Mississippi, Nebraska, Oklahoma, South Carolina and Wyoming—could be limited to a single marketplace insurer statewide.

“As Obamacare continues to collapse, the administration is considering its options on how to address the challenges Americans are facing by canceled plans, higher costs, and failing markets,” HHS spokeswoman Alleigh Marré said in a statement to POLITICO.

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.